NCT00004494View on ClinicalTrials.gov

Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 1998

Conditions

SepsisRespiratory Distress SyndromeRespiratory Distress Syndrome, Adult

Interventions

DRUG

vasoactive intestinal peptide

Trial Locations (2)

11768

Veterans Affairs Medical Center - Northport, Northport

11790-7775

State University of New York Health Sciences Center - Stony Brook, Stony Brook

All Listed Sponsors

collaborator

State University of New York

OTHER

collaborator

FDA Office of Orphan Products Development

FED

lead

Stony Brook University

OTHER

NCT00004494 - Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis | Biotech Hunter | Biotech Hunter